Skip to Content

Sponsors

No results

Keywords

No results

Types

No results

Search Results

Events

No results
Search events using: keywords, sponsors, locations or event type
When / Where
All occurrences of this event have passed.
This listing is displayed for historical purposes.

Presented By: DCMB Seminar Series

DCMB / CCMB Weekly Seminar featuring Karen Miga, PhD (UC Santa Cruz Genomics Institute)

"From complete genomes to pangenomes: Expanding our understanding of human haplotype variation"

Abstract: The initial Human Genome Project was a landmark achievement, serving as an essential resource for basic and clinical science, as well as for understanding human history, for over two decades. However, it needs an upgrade due to missing data, inaccurately assembled regions, and its inability to fully represent and identify sequence variants equitably. A single reference map, regardless of its completeness, cannot encapsulate the variation across the human population, leading to biases and ultimately inequity in genomic studies. Recognizing this limitation, the new initiative known as the Human Pangenome Project aims to deliver hundreds of highly accurate and complete genomes. This effort intends to define all bases of each chromosome from telomere to telomere (T2T), ensuring a broader representation of common variants across the human species. Achieving these goals will require the rise of new tools and technology standards for complete genome assemblies and pangenomics, which will have broad and lasting impact on genomic research.

Short bio: Throughout her career, she has developed innovative computational and experimental approaches to advance understanding of centromeric and pericentromeric DNAs. She works at the forefront of genome technologies as part of the T2T and Pangenome initiative to construct genetic and epigenetic maps to expand our understanding of their structure and function. As a group leader, she prioritizes fostering a creative and scientifically rigorous environment that supports inclusivity and diversity within our scientific team. She also prioritizes training that operates at the intersection of science, justice, and equity.

Back to Main Content